Investors

Discover Virbac's Statement on extra-financial performance

SALES 2023
1,247 M€
59%
Companion
animals
41%
Farm
animals

(in € million)

Financial public release
& News

Virbac licenses MabGenesis’ therapeutic antibodies for canine diseases

2025/04/16 - Financial public releases

Vignette_corpo_mabgenesis.jpgDiscover the press release issued on April 16, 2025.

Read more

2025 first quarter consolidated sales

2025/04/15 - Financial public releases

In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope

Read more

2024 annual results

2025/03/13 - Financial public releases

●    Very strong revenues increase of 13.6% at constant exchange rates, driven by:
      ○  dynamic organic growth (+7.5%) 
      ○  strategic contribution of our acquisitions (+6.1%)

●    2024 operating income2 at an all-time high of 16.6% of revenues (16.0% excluding
      acquisitions)
      ○  up by 1.5 percentage points compared to 2023 

●    Positive trend for 2025
      ○  sales growth expected between 4% and 6% at constant exchange rates and scope
      ○  operating income relatively stable at around 16%, excluding the impact of acquisitions

Read more

Events
Thursday June 19

Annual Ordinary General Meeting

From 2025/06/19

Read moreRead less

Thursday June 19, 2025

Annual Ordinary General Meeting

Wednesday July 16

2025 second quarter sales

From 2025/07/16

Read moreRead less

Wednesday july 16, 2025 after market close

2025 second quarter sales
(quiet period from July 2, 2025)

Friday September 12

2025 interim result

From 2025/09/12

Read moreRead less

Friday September 12, 2025 after market close

2025 interim result
(quiet period from August 15, 2025)

Past Events
Tuesday April 15

2025 first quarter sales

From 2025/04/15

Read moreRead less

Tuesday April 15, 2025 after market close

2025 first quarter sales
(quiet period from April 1, 2024)

Friday March 14

SFAF meeting - 2024 financial & strategic information

From 2025/03/14

Read moreRead less

Friday March 14, 2025
SFAF meeting - 2024 financial & strategic information
Thursday March 13

2024 results

From 2025/03/13

Read moreRead less

Thursday March 13, 2024 after market close

2024 results
(quiet period from February 13, 2025)​

For more financial information

For more financial information

finances@virbac.com